Cargando…
Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model
Spinal tuberculosis (ST) is the tuberculosis caused by Mycobacterium tuberculosis (Mtb) infections in spinal curds. Isoliquiritigenin 4,2′,4′-trihydroxychalcone, ISL) is an anti-inflammatory flavonoid derived from licorice (Glycyrrhiza uralensis), a Chinese traditional medicine. In this study, we ev...
Autores principales: | Wang, Wenjing, Yang, Baozhi, Cui, Yong, Zhan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019872/ https://www.ncbi.nlm.nih.gov/pubmed/29962851 http://dx.doi.org/10.4196/kjpp.2018.22.4.369 |
Ejemplares similares
-
Isoliquiritigenin Attenuates Adipose Tissue Inflammation in vitro and Adipose Tissue Fibrosis through Inhibition of Innate Immune Responses in Mice
por: Watanabe, Yasuharu, et al.
Publicado: (2016) -
Roles of monocyte chemotactic protein 1 and nuclear factor-κB in immune response to spinal tuberculosis in a New Zealand white rabbit model
por: Guo, X.H., et al.
Publicado: (2017) -
Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
por: Du, Fen, et al.
Publicado: (2016) -
Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity
por: Zhu, Xiaobo, et al.
Publicado: (2019) -
Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
por: Qi, Jie, et al.
Publicado: (2020)